USD
$0.00
(0.00%
)At Close (As of Sep 5, 2025)
$21.72M
Market Cap
1.622
P/E Ratio
2.3
EPS
$4.44
52 Week High
$0.44
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $6.5M |
Total Revenue | $9.8M |
Cost Of Revenue | $3.3M |
Costof Goods And Services Sold | $3.3M |
Operating Income | -$5.8M |
Selling General And Administrative | $7.4M |
Research And Development | $42K |
Operating Expenses | $12M |
Investment Income Net | - |
Net Interest Income | -$904K |
Interest Income | $96K |
Interest Expense | $904K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $381K |
Income Before Tax | -$7.2M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$7.2M |
Comprehensive Income Net Of Tax | - |
Ebit | -$6.3M |
Ebitda | -$5.9M |
Net Income | -$7.2M |
Field | Value (USD) |
---|---|
Total Assets | $3.4M |
Total Current Assets | $1.9M |
Cash And Cash Equivalents At Carrying Value | $430K |
Cash And Short Term Investments | $430K |
Inventory | $765K |
Current Net Receivables | $389K |
Total Non Current Assets | $1.5M |
Property Plant Equipment | $1M |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $351K |
Other Non Current Assets | - |
Total Liabilities | $3.6M |
Total Current Liabilities | $2.8M |
Current Accounts Payable | $623K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $963K |
Total Non Current Liabilities | $709K |
Capital Lease Obligations | $1.1M |
Long Term Debt | - |
Current Long Term Debt | $565K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.7M |
Other Current Liabilities | $769K |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$129K |
Treasury Stock | - |
Retained Earnings | -$183M |
Common Stock | $49K |
Common Stock Shares Outstanding | $3.4M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$5.2M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $381K |
Capital Expenditures | $6K |
Change In Receivables | - |
Change In Inventory | -$272K |
Profit Loss | - |
Cashflow From Investment | $1.1M |
Cashflow From Financing | $1.5M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $3.1M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$7.1M |
Field | Value (USD) |
---|---|
Gross Profit | $6.5M |
Total Revenue | $9.8M |
Cost Of Revenue | $3.3M |
Costof Goods And Services Sold | $3.3M |
Operating Income | -$5.8M |
Selling General And Administrative | $7.4M |
Research And Development | $42K |
Operating Expenses | $12M |
Investment Income Net | - |
Net Interest Income | -$904K |
Interest Income | $96K |
Interest Expense | $904K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $381K |
Income Before Tax | -$7.2M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$7.2M |
Comprehensive Income Net Of Tax | - |
Ebit | -$6.3M |
Ebitda | -$5.9M |
Net Income | -$7.2M |
Field | Value |
---|---|
Ex Dividend Date | 2025-09-30 |
Declaration Date | 2025-08-26 |
Record Date | 2025-09-15 |
Payment Date | 2025-09-29 |
Amount | 0.8 |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
NovaBay Pharmaceuticals, Inc., a medical device company, develops products for the eye care markets in the United States and internationally. The company is headquartered in Emeryville, California.